IBO fundamentals
Key facts
Market capitalization8.24 MCAD
Basic EPS (TTM)−0.01CAD
Founded2018
CEONicholas Peter Karos
Websiteuniversalibogaine.com
About
Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company was founded by Shayne Nyquvest and Alberto Solá Agulló in 2018 and is headquartered in Calgary, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−175%
−140%
−105%
−70%
−35%
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
−1.00 M
−500.00 K
0.00
500.00 K
1.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Dividends
Dividend yield, history and sustainability
No dividends
IBO has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company